BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
Go back to BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL| (NASDAQ: BGNE) | Delayed: 184.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $184.71 | 52 Week High | $36.76 | |||
| Open | $184.71 | 52 Week Low | $22.51 | |||
| Day High | $184.71 | P/E | N/A | |||
| Day Low | $184.71 | EPS | $0.00 | |||
| Volume | 2,720,881 | |||||
